Amlodipine And Valsartan
Product Images NDC 45865-889

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 45865-889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (889)

Amlodipine and Valsartan Tablets 10 mg/160 mg packaging label by Medsource Pharmaceuticals. The label specifies the generic for Exforge with yellow oblong tablets imprinted with '014' and film-coated. The label includes lot and expiration data fields, usage warnings, and dosing instructions on the front panel.*

FDA Label Image

Image-01 (B5a13389 E39e 4825 A6dc 4ba50d432aed 01)

A line graph comparing the percentage of systolic blood pressure (SBP) below 140 mmHg versus baseline SBP values (140-180 mmHg) for Amlodipine and Valsartan Tablets 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo groups. Each treatment group is represented by a distinct line style and marker.*

FDA Label Image

Image-02 (B5a13389 E39e 4825 A6dc 4ba50d432aed 02)

A line graph comparing the percentage of patients achieving diastolic blood pressure (DBP) below 90 mmHg over a range of systolic blood pressure (SBP) from 95 to 110 mmHg. The graph includes data lines for Amlodipine and Valsartan Tablets 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo, showing the relative efficacy of each treatment.*

FDA Label Image

Image-03 (B5a13389 E39e 4825 A6dc 4ba50d432aed 03)

A line graph comparing the percentage of subjects with systolic blood pressure (SBP) less than 130 mmHg across different baseline SBP values. It includes data series for Amlodipine and Valsartan tablets 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo, showing percentage response trends as baseline SBP increases from 140 to 180 mmHg.*

FDA Label Image

Image-04 (B5a13389 E39e 4825 A6dc 4ba50d432aed 04)

A line graph comparing the percentage of diastolic blood pressure (DBP) less than 80 mmHg against baseline DBP (mmHg) for Amlodipine and Valsartan 10/320 mg tablets, Valsartan 320 mg, Amlodipine 10 mg, and placebo groups. The graph uses distinct markers for each group as indicated in the legend.*

FDA Label Image

Amlodipineandvals-figure-01 (B5a13389 E39e 4825 A6dc 4ba50d432aed 05)

Chemical structure diagram showing two molecular structures, one with a chlorine-substituted phenyl group and ester functionalities, likely representing amlodipine, and the other a benzene sulfonic acid structure, consistent with valsartan or a related component.*

FDA Label Image

Amlodipineandvals-figure-02 (B5a13389 E39e 4825 A6dc 4ba50d432aed 06)

Chemical structure of the active ingredient in Amlodipine and Valsartan as shown, depicting molecular bonds and groups including aromatic rings, nitrogen atoms, and other functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.